107 related articles for article (PubMed ID: 10592433)
1. GnRH analogues and uterine leiomyomas. Effect of hormone replacement therapy on cell proliferation.
Rintala S; Kujansuu E; Teisala K; Rantala I; Kivinen S; Tuimala R
Gynecol Obstet Invest; 1999; 48(4):276-9. PubMed ID: 10592433
[TBL] [Abstract][Full Text] [Related]
2. Hormonal therapy before surgical treatment for uterine leiomyomas.
Moghissi KS
Surg Gynecol Obstet; 1991 Jun; 172(6):497-502. PubMed ID: 1827931
[TBL] [Abstract][Full Text] [Related]
3. Involvement of parathyroid hormone-related peptide in cell proliferation activity of human uterine leiomyomas.
Yoshida M; Ohtsuru A; Samejima T; Okazaki M; Fujishita A; Ito M; Yamashita S; Ishimaru T
Endocr J; 1999 Feb; 46(1):81-90. PubMed ID: 10426571
[TBL] [Abstract][Full Text] [Related]
4. The histopathology of uterine leiomyomas following treatment with gonadotropin-releasing hormone analogues.
Colgan TJ; Pendergast S; LeBlanc M
Hum Pathol; 1993 Oct; 24(10):1073-7. PubMed ID: 8406417
[TBL] [Abstract][Full Text] [Related]
5. Suppression of cell proliferation and induction of apoptosis in uterine leiomyoma by gonadotropin-releasing hormone agonist (leuprolide acetate).
Mizutani T; Sugihara A; Nakamuro K; Terada N
J Clin Endocrinol Metab; 1998 Apr; 83(4):1253-5. PubMed ID: 9543151
[TBL] [Abstract][Full Text] [Related]
6. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J
Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
[TBL] [Abstract][Full Text] [Related]
7. GnRH analogue-induced uterine shrinkage enabling a vaginal hysterectomy and repair in large leiomyomatous uteri.
Schneider D; Golan A; Bukovsky I; Pansky M; Caspi E
Obstet Gynecol; 1991 Sep; 78(3 Pt 2):540-1. PubMed ID: 1831252
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological changes of uterine leiomyomas after GnRH agonist therapy.
Grigoriadis C; Papaconstantinou E; Mellou A; Hassiakos D; Liapis A; Kondi-Pafiti A
Clin Exp Obstet Gynecol; 2012; 39(2):191-4. PubMed ID: 22905461
[TBL] [Abstract][Full Text] [Related]
9. Effect of steroid add-back therapy on the proliferative activity of uterine leiomyoma cells under gonadotropin-releasing hormone agonist therapy.
Mizutani T; Sugihara A; Honma H; Komura H; Nakamuro K; Terada N
Gynecol Endocrinol; 2005 Feb; 20(2):80-3. PubMed ID: 15823826
[TBL] [Abstract][Full Text] [Related]
10. Morphological changes in uterine leiomyomas treated by GnRH agonist goserelin.
Crow J; Gardner RL; McSweeney G; Shaw RW
Int J Gynecol Pathol; 1995 Jul; 14(3):235-42. PubMed ID: 8600075
[TBL] [Abstract][Full Text] [Related]
11. [Preoperative treatment with GnRH analogs in hysterectomy].
Serrao L; Brizzi C; Primiero FM
Clin Ter; 1994 Nov; 145(11):403-6. PubMed ID: 7889725
[TBL] [Abstract][Full Text] [Related]
12. Maintenance of increased Bcl-2 expression in uterine leiomyomas after GnRH agonist therapy.
Khurana KK; Singh SB; Tatum AH; Schulz V; Badawy SZ
J Reprod Med; 1999 Jun; 44(6):487-92. PubMed ID: 10394541
[TBL] [Abstract][Full Text] [Related]
13. GnRH agonists before surgery for uterine leiomyomas. A review.
Crosignani PG; Vercellini P; Meschìa M; Oldani S; Bramante T
J Reprod Med; 1996 Jun; 41(6):415-21. PubMed ID: 8799917
[TBL] [Abstract][Full Text] [Related]
14. Prospective randomised trial comparing gonadotrophin-releasing hormone analogues with triple tourniquets at open myomectomy.
Al-Shabibi N; Chapman L; Madari S; Papadimitriou A; Papalampros P; Magos A
BJOG; 2009 Apr; 116(5):681-7. PubMed ID: 19191779
[TBL] [Abstract][Full Text] [Related]
15. Massive lymphocytic infiltration of uterine leiomyomas associated with GnRH agonist treatment.
Bardsley V; Cooper P; Peat DS
Histopathology; 1998 Jul; 33(1):80-2. PubMed ID: 9726054
[TBL] [Abstract][Full Text] [Related]
16. Clinical use of nafarelin in the treatment of leiomyomas. A review of the literature.
Minaguchi H; Wong JM; Snabes MC
J Reprod Med; 2000 Jun; 45(6):481-9. PubMed ID: 10900582
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of the acceptability and effect of goserelin and nafarelin on endometriosis.
Bergqvist A;
Gynecol Endocrinol; 2000 Dec; 14(6):425-32. PubMed ID: 11228063
[TBL] [Abstract][Full Text] [Related]
18. Morphometric and electron microscopic analyses of the effect of gonadotropin-releasing hormone agonist treatment on arteriole size in uterine leiomyomas.
Kalir T; Wu H; Gordon RE; Gil J
Arch Pathol Lab Med; 2000 Sep; 124(9):1295-8. PubMed ID: 10975924
[TBL] [Abstract][Full Text] [Related]
19. A double-blind randomized study of the treatment of endometriosis with nafarelin or nafarelin plus norethisterone.
Bergqvist A; Jacobson J; Harris S
Gynecol Endocrinol; 1997 Jun; 11(3):187-94. PubMed ID: 9209899
[TBL] [Abstract][Full Text] [Related]
20. Fibroids (uterine myomatosis, leiomyomas).
Lethaby A; Vollenhoven B
Clin Evid; 2005 Dec; (14):2264-82. PubMed ID: 16620489
[No Abstract] [Full Text] [Related]
[Next] [New Search]
